Pendium

Step 1 of 9

AI agents see Neutrogena as a category standard, but the lead is narrowing.

You are currently a top-three brand in AI visibility, though you're being challenged by CeraVe on barrier care and The Ordinary on pure actives.

Neutrogena's baseline score
78/100
Good

Neutrogena is a dominant force in AI discovery, benefiting from decades of dermatological authority and massive editorial coverage. While your visibility is excellent, AI agents are beginning to shift some 'clinical value' recommendations to newer competitors like CeraVe.

What we see
  • Neutrogena maintains high visibility (approx. 15%) in Q1 2026 AI discovery indices, ranking just behind CeraVe and La Roche-Posay.
  • The Skin360 tool provides a significant data-driven visibility advantage that AI agents can describe as a unique brand feature.
  • A gap exists in 'clean beauty' prompts where AI agents favor boutique brands over heritage mass-market players despite Neutrogena's 'Ultra Gentle' range.
  • Competitors like The Ordinary are mentioned more frequently for 'active ingredient' specific queries (e.g., '1% retinol').
Business goals Neutrogena is likely trying to hit
  • Defend market share against ingredient-led budget brands like The Ordinary
  • Scale the Skin360 AI analysis tool to drive personalized product regimen sales
  • Capture Gen Z loyalty through the 'Break the Rules' science-first campaign
  • Maintain dermatologist-recommended status as the primary brand differentiator